CCDC117 Antikörper (AA 148-250) (AbBy Fluor® 350)

Produktnummer ABIN887052

Produktdetails anti-CCDC117 Antikörper (AbBy Fluor® 350)

Target: CCDC117 (Coiled-Coil Domain Containing 117 (CCDC117))

Bindungsspezifität: AA 148-250

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CCDC117 Antikörper ist konjugiert mit AbBy Fluor® 350

Applikation: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CCDC117

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu CCDC117

Target: CCDC117 (Coiled-Coil Domain Containing 117 (CCDC117))

Andere Bezeichnung: CCDC117 (CCDC117 Produkte)

Synonyme: dJ366L4.1 antikoerper, 1110004K02Rik antikoerper, 1700026O03Rik antikoerper, AU018638 antikoerper, AU042822 antikoerper, AV173073 antikoerper, BC018601 antikoerper, coiled-coil domain containing 117 antikoerper, CCDC117 antikoerper, Ccdc117 antikoerper

Hintergrund:

Synonyms: CC117_HUMAN, Ccdc117, Coiled-coil domain-containing protein 117.

Background: CCDC117 is a 279 amino acid protein that is expressed as multiple alternatively spliced isoforms and is encoded by a gene which maps to human chromosome 22. Chromosome 22 houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, Neurofibromatosis type 2, autism and schizophrenia. Additionally, translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein Bcr-Abl, a potent cell proliferation activator found in several types of leukemias.

Gen-ID: 150275